Why the study?
Does intrapericardial cisplatin prevent recurrence of neoplastic cardiac tamponade in a patient with disseminated osteogenic sarcoma?
Does intrapericardial cisplatin prevent recurrence of neoplastic cardiac tamponade in a patient with disseminated osteogenic sarcoma?
Intrapericardial instillation of cisplatin following pericardiocentesis may be an effective and safe palliative treatment to prevent recurrence of neoplastic cardiac tamponade.
Answers are grounded in this paper and cite their sources.
May support intrapericardial cisplatin to prevent neoplastic tamponade recurrence; hypothesis-generating and requires prospective validation.
A young patient with disseminated osteogenic sarcoma presented with cardiac tamponade. She was successfully managed with pericardiocentesis and intrapericardial instillation of cisplatin. There was no reaccumulation of pericardial fluid or recurrence of tamponade until the patient's death 12 months later. Intrapericardial chemotherapy may be effective in the management of cardiac tamponade secondary to malignancy.
No takes yet. Share an insight, caveat, or question.
Siddiqui et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: